Core Insights - The article highlights RadNet's record Q4 performance driven by a 14.1% increase in advanced imaging volumes, which now account for over 60% of total revenue and serve as the primary margin catalyst [1] - Management attributes this volume growth to a structural shift in procedural care from expensive hospital settings to RadNet's lower-cost ambulatory freestanding centers [1] - The acquisition of Paris-based Gleamer positions RadNet as the world's largest radiology clinical AI provider, adding 700 customer contracts across 44 countries to the DeepHealth portfolio [1] - Operational efficiency is being enhanced through 'agentic AI' and automated draft reporting to address global shortages of radiologists and technologists [1] - The strategic focus on 'routine imaging' (X-ray, ultrasound, mammography) aims to capture high-volume workflows that represent approximately 25% of RadNet's total imaging volume [1] - The company maintained a disciplined capital structure, ending 2025 with a net debt to adjusted EBITDA leverage ratio of approximately 1.0 despite significant acquisition activity [1]